Moderna
MRNA
#1636
Rank
NZ$17.22 B
Marketcap
$44.54
Share price
-7.18%
Change (1 day)
-73.53%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

P/S ratio for Moderna (MRNA)

P/S ratio as of April 2025 (TTM): 3.11

According to Moderna 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.9126. At the end of 2024 the company had a P/S ratio of 4.83.

P/S ratio history for Moderna from 2018 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20244.83-14.02%
20235.6153.56%
20223.66-37.03%
20215.81-96.15%
20201519.95%
2019137235.08%
201840.9

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
3.40 9.36%๐Ÿ‡บ๐Ÿ‡ธ USA
10.4 234.92%๐Ÿ‡บ๐Ÿ‡ธ USA
15.1 385.33%๐Ÿ‡บ๐Ÿ‡ธ USA
4.29 37.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
662 21,201.91%๐Ÿ‡บ๐Ÿ‡ธ USA
4.34 39.44%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA